Unresolved questions associated with the management of ventricular preexcitation syndrome

Pacing and Clinical Electrophysiology : PACE
Béatrice Brembilla-PerrotJean-Marc Sellal

Abstract

Many recent recommendations concern the management of preexcitation syndrome. In clinical practice, they are sometimes difficult to use. The purpose of the authors was to discuss the main problems associated with this management. Three problems are encountered: (1) the reality of the absence of symptoms or the interpretation of atypical symptoms, (2) the electrocardiographic diagnosis of preexcitation syndrome that can be missed, and (3) the exact electrophysiological protocol and its interpretation used for the evaluation of the prognosis. Because of significant progress largely related to the development of curative treatment, it seems easy to propose ablation in many patients despite the related risks of invasive studies and to minimize the invasive risk by only performing ablation for patients with at-risk pathways. However, there is a low risk of spontaneous events in truly asymptomatic patients and the indication of accessory pathway ablation should be discussed case by case.

References

Nov 15, 1979·The New England Journal of Medicine·G J KleinJ J Gallagher
Aug 1, 1992·Pacing and Clinical Electrophysiology : PACE·M ChimientiJ A Salerno
Jan 15, 1991·The American Journal of Cardiology·W S TeoC J Murdock
Feb 1, 1991·European Heart Journal·P T MontoyaR Oter
Apr 1, 1990·The American Journal of Cardiology·C J GarrattA J Camm
Aug 1, 1987·British Heart Journal·B Brembilla-PerrotC Pernot
May 1, 1986·The American Journal of Cardiology·S MilsteinG J Klein
May 1, 1984·European Heart Journal·B PerrotG Faivre
Sep 1, 1995·The American Journal of Cardiology·C TimmermansH J Wellens
Apr 1, 1993·European Heart Journal·B Brembilla-Perrot, R Ghawi
Nov 11, 1998·Journal of the American College of Cardiology·R VitielloL N Benson
Nov 7, 2003·The New England Journal of Medicine·Carlo PapponeSalvatore Rosanio
Sep 17, 2004·The New England Journal of Medicine·Carlo PapponeVincenzo Santinelli
Aug 3, 2007·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·B Brembilla-PerrotF Marçon
Jan 17, 2009·Journal of the American College of Cardiology·Vincenzo SantinelliCarlo Pappone
Oct 8, 2009·Circulation. Arrhythmia and Electrophysiology·George J KleinRaymond Yee
May 22, 2010·Pacing and Clinical Electrophysiology : PACE·Béatrice Brembilla-PerrotChristine Suty-Selton
Dec 16, 2010·Circulation. Arrhythmia and Electrophysiology·Jeremy P MooreFrank A Fish
Jan 18, 2011·International Journal of Cardiology·Béatrice Brembilla-PerrotArnaud Terrier de la Chaise
May 26, 2011·Pacing and Clinical Electrophysiology : PACE·Richard J CzosekTimothy K Knilans
Jun 28, 2011·International Journal of Cardiology·Béatrice Brembilla-PerrotArnaud Terrier de la Chaise
Nov 14, 2012·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Béatrice Brembilla-PerrotArnaud Terrier de la Chaise
Jan 15, 2013·Journal of Electrocardiology·Maheshwar PauriahBéatrice Brembilla-Perrot
Feb 6, 2013·Pacing and Clinical Electrophysiology : PACE·Philip WackelGaurav Arora
Feb 27, 2013·Pacing and Clinical Electrophysiology : PACE·Béatrice Brembilla-PerrotFrançois Marçon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.